Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment

European Journal of Clinical Pharmacology

Volumn 63, Issue 3, 2007, Pages 271-278

  Charles, B G ^a   Blomgren, A ^a   Nasveld, P E ^b   Kitchener, S J ^b   Jensen, A ^b   Gregory, R M ^b   Robertson, B ^b   Harris, I E ^b   Reid, M P ^b   Edstein, M D ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

Healthy subjects; Malaria prophylaxis; Mefloquine; NONMEM; Population pharmacokinetics

Indexed keywords

MEFLOQUINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; LOADING DRUG DOSE; MALARIA; MALE; NORMAL HUMAN; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLDIER;

ADOLESCENT; ADULT; ANTIMALARIALS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALARIA; MALE; MEFLOQUINE; MIDDLE AGED; MILITARY PERSONNEL; MODELS, BIOLOGICAL;

EID: 33846913940     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-006-0247-3     Document Type: Article

References (35)

1. World Health Organization "International Travel and Health" 2005. Available at: http://www.who.int/malaria
2. US Center for Disease Control. Available at: http://www.cdc.gov/travel/ malariadrugs.htm
3. Sanchez JL, DeFraites RF, Sharp TW, Hanson RK (1993) Mefloquine or doxycycline prophylaxis in US troops in Somalia. Lancet 341:1021-1022
4. Peragallo MS, Sabatinelli G, Sarnicola G (1999) Compliance and tolerability of mefloquine and chloroquine plus proguanil for long-term malaria chemoprophylaxis in groups at particular risk (the military). Trans R Soc Trop Med Hyg 93:73-77
5. Boudreau E, Schuster B, Sanchez J, Novakowski W, Johnson R, Redmond D, Hanson R, Dausel L (1993) Tolerability of prophylactic Lariam® regimens. Trop Med Parasitol 44:257-265
6. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC (1993) Long-term malaria prophylaxis with weekly mefloquine. Lancet 341:848-851
7. Steffen R, Fuchs E, Schildknecht J, Naef U, Funk M, Schlagenhauf P, Phillips-Howard P, Nevill C, Sturchler D (1993) Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet 341:1299-1303
8. Jaspers CA, Hopperus Buma AP, van Thiel PP, van Hulst RA, Kager PA (1996) Tolerance of mefloquine chemoprophylaxis in Dutch military personnel. Am J Trop Med Hyg 55:230-234
9. Ohrt C, Richie TL, Widjaja H, Shanks GD, Fitriadi J, Fryauff DJ, Handschin J, Tang D, Sandjaja B, Tjitra E, Hadiarso L, Watt G, Wignall FS (1997) Mefloquine compared with doxycycline for the prophylaxis ofmalaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled Group. Ann Intern Med 126:963-972
10. Schlagenhauf P, Lobel H, Steffen R, Johnson R, Popp K, Tschopp A, Letz R, Crevoiser C (1997) Tolerance of mefloquine by SwissAir trainee pilots. Am J Trop Med Hyg 56:235-240
11. Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD (2001) Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis 33:1015-1021
12. Schlagenhauf P, Tschopp A, Johnson R, Nothdurft HD, Beck B, Schwartz E, Herold M, Krebs B, Veit O, Allwinn R, Steffen R (2003) Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study. BMJ 327:1078-1084
13. Looareesuwan S, White NJ, Warrell DA, Forgo I, Dubach UG, Ranalder UB, Schwartz DE (1987) Studies of mefloquine bioavailability and kinetics using a stable isotope technique: a comparison of Thai patients with falciparum malaria and healthy Caucasian volunteers. Br J Clin Pharmacol 24:37-42
14. Desjardins RE, Pamplin CL, von Bredow J, Barry KG, Canfield CJ (1979) Kinetics of a new antimalarial, mefloquine. Clin Pharmacol Ther 26:372-379
15. Weidekamm E, Schwartz DE, Dubach UC,Weber B (1987) Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef. Chemotherapy 33:259-265
16. Karbwang J, Back DJ, Bunnag D, Breckenridge AM (1988) A comparison of the pharmacokinetics of mefloquine in healthy Thai volunteers and in Thai patients with falciparum malaria. Eur J Clin Pharmacol 35:677-680
17. Franssen G, Rouveix B, Lebras J, Bauchet J, Verdier F, Michon C, Bricaire F (1989) Divided-dose kinetics of mefloquine in man. Br J Clin Pharmacol 28:179-184
18. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Na Bangchang K, Karbwang J, White NJ (1991) Mefloquine pharmacokinetics and resistance in children with acute falciparum malaria. Br J Clin Pharmacol 31:556-559
19. Pennie RA, Koren G, Crevoisier C (1993) Steady-state pharmacokinetics of mefloquine in long-term travellers. Trans R Soc Trop Med Hyg 87:459-462
20. Mimica I, Fry W, Eckert G, Schwartz DE (1983) Multiple-dose kinetic study of mefloquine in healthy male volunteers. Chemotherapy 29:184-187
21. Schwartz DE, Weidekamm E, Mimica I, Heizmann P, Portmann R (1987) Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects. Chemotherapy 33:1-8
22. Nasveld P, Brennan L, Edstein M, Kitchener S, Leggat P, Rieckmann K Randomised, double-blind comparative study to evaluate the safety, tolerability and effectiveness of tafenoquine and mefloquine for the prophylaxis of malaria in non-immune Australian soldiers. 51st annual meeting of American Society of Tropical Medicine and Hygiene, Denver, USA, November 2002
23. Kitchener SJ, Nasveld PE, Gregory RM, Edstein MD (2005) Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor. Med J Aust 182:168-171
24. Riviere JH, Back DJ, Breckenridge AM, Howells RE (1985) The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism. Br J Clin Pharmacol 20:469-474
25. Bergqvist Y, Hellgren U, Churchill FC (1988) High-performance liquid chromatographic assay for the simultaneous monitoring of mefloquine and its acid metabolite in biological samples using protein precipitation and ion-pair extraction. J Chromatogr 432:253-263
26. Simpson JA, Price R, ter Kuile F, Teja-Isavatharm P, Nosten F, Chongsuphajaisiddhi T, Looareesuwan S, Aarons L, White NJ (1999) Population pharmacokinetics of mefloquine in patients with acute falciparum malaria. Clin Pharmacol Ther 66:472-484
27. Ashley EA, Stepniewska K, Lindegardh N, McGready R, Hutagalung R, Hae R, Singhasivanon P, White NJ, Nosten F (2006) Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria. Antimicrob Agents Chemother 50:2281-2285
28. Svensson USH, Alin MH, Karlsson MO, Bergqvist Y, Ashton M (2002) Population pharmacokinetic and pharmacodynamic modelling of artemisinin and mefloquine enantiomers in patients with falciparum malaria. Eur J Clin Pharmacol 58:339-351
29. Price R, Simpson JA, Teja-Isavatharm P, Than MM, Luxemburger C, Heppner DG, Chongsuphajaisiddhi T, Nosten F, White NJ (1999) Pharmacokinetics of mefloquine combined with artesunate in children with acute falciparum malaria. Antimicrob Agents Chemother 43:341-346
30. Dao NVH, Quoc NP, Ngoa ND, Thuy LT, The ND, Dai B, Binh VQ, Rieckmann KH, Edstein MD (2005) Fatty-food does not alter blood mefloquine concentrations in the treatment of falciparum malaria. Trans Roy Soc Trop Med Hyg 99:927-931
31. Schwartz E, Paul F, Pener H, Almog S, Rotenberg M, Golenser J (2001) Malaria antibodies and mefloquine levels among United Nations troops in Angola. J Travel Med 8:113-116
32. Schwartz E, Potasman I, Rotenberg M, Almog S, Sadetzki S (2001) Serious adverse events of mefloquine in relation to blood level and gender. Am J Trop Med Hyg 65:189-192
33. Slutsker LM, Khoromana CO, Payne D, Allen CR, Wirima JJ, Heymann DL, Patchen L, Steketee RW (1990) Mefloquine therapy for Plasmodium falciparum malaria in children under 5 years of age in Malawi: in vivo/in vitro efficacy and correlation of drug concentration with parasitological outcome. Bull World Health Organ 68:53-59
34. Beal SL (2001) Ways to fit a PK model with some data below the quantification limit. J Pharmacokin Pharmacodyn 28:481-504
35. Yano Y, Beal SL, Sheiner LB (2001) Evaluating pharmacokinetic/ pharmacodynamic models using the posterior predictive check. J Pharmacokinet Pharmacodyn 28:171-192